Lung Disease Study Uses Multi-Modal Technology to Reach Participants Increase in Study Efficacy Highlights Automated Telephone Software from Inventive Labs

Share Article

Inventive Labs Corporation, a provider of telephony software and application services, and the COPDGene® Study, one of the largest studies ever to investigate the underlying genetic factors of Chronic Obstructive Pulmonary Disease or COPD, announced today the successful implementation of a web and telephone-based longitudinal follow-up solution.

The customized software and service encompasses various forms of communication and technology that increase our chances for Study participation.

Inventive Labs Corporation, a provider of telephony software and application services, and the COPDGene® Study, one of the largest studies ever to investigate the underlying genetic factors of Chronic Obstructive Pulmonary Disease or COPD, announced today the successful implementation of a web and telephone-based longitudinal follow-up solution.

The solution, powered by Inventive Labs' Voice Elements software, automates the initial and quarterly follow-up calls to participants, enabling them to respond to study questions by either Touch Tone (pressing digits) or their voice, using speech recognition. Not only does the system gather data for willing participants, but also informs the COPDGene® Study if a participant is unreachable or unwilling to continue participation.

Before the system was installed, Study coordinators had to manage calling the participants, often multiple times, which "ate up" regional Study resources. Inventive Labs' solution integrates a web survey, in addition to the telephone survey, and streamlines data gathering and follow-up management.

"Using Inventive Labs' solution helps the COPDGene Study stay focused on advancing the treatment options and cure strategies for COPD," commented James D. Crapo M.D, Professor of Medicine, National Jewish Health, and University of Colorado Denver and co-founder of the COPDGene® Study. "The customized software and service encompasses various forms of communication and technology that increase our chances for Study participation."

"We were pleased to apply our broad services offerings to the successful deployment of the COPDGene® Study project," said Ron Tanner, president of Inventive Labs. "Bringing telephony, IVR, speech recognition and web technology together highlights how well-constructed automation can provide enormous benefits to organizations such as COPDGene®."

About Inventive Labs
Inventive Labs is a leading provider of telephony application solutions. The company's products and related services, including Voice Elements, dramatically reduce the time, cost and complexity of creating voice solutions.

For more information, please visit: http://www.voiceelements.com/
About COPDGene®

COPD or Chronic Obstructive Pulmonary Disease is the fourth leading cause of death in the United States and affects the lives of over 12 million people. There are many risk factors for developing COPD with cigarette smoking being the most common. The goal of the COPDgene® Study is to discover what heritable or genetic factors contribute to the development of COPD in some people. Through continuing collaboration with physicians and researchers across the country, COPDGene® continues to expand and discover exciting new information on the development and progression of COPD.

For more information, please visit: http://www.copdgene.org/

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Laura Kennedy
Visit website